Amy Killelea

发表

Addressing ethical challenges in US-based HIV phylogenetic research.

Lisa M. Lee, S. Little, Lisa M Lee, 2020, The Journal of infectious diseases.

Regional Disparities in Qualified Health Plans’ Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States

K. McManus, E. R. Rogawski McQuade, Amy Killelea, 2020, JAMA network open.

Long-Acting Cabotegravir for HIV Prevention: Issues of Access, Cost, and Equity.

J. Sharfstein, D. Dangerfield, Amy Killelea, 2022, JAMA.

Access to Medications for Opioid Use Disorder for Persons With Human Immunodeficiency Virus in the United States: Gaps in Coverage by State AIDS Drug Assistance Programs

K. McManus, Asher J Schranz, Thibaut Davy-Mendez, 2022, Open forum infectious diseases.

Considerations for Modernized Criminal HIV Laws and Assessment of Legal Protections Against Release of Identified HIV Surveillance Data for Law Enforcement.

N. Benbow, Z. Lazzarini, C. Galletly, 2019, American Journal of Public Health.

Associated Costs Are a Barrier to HIV Preexposure Prophylaxis Access in the United States.

K. McManus, Amy Killelea, Andrew Strumpf, 2022, American journal of public health.

Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic

C. Beyrer, R. Conti, J. Sharfstein, 2022, Journal of Law, Medicine & Ethics.

Investing in National HIV PrEP Preparedness

Amy Killelea, Jeremiah Johnson, K. Farrow, 2023, New England Journal of Medicine.

INTRODUCTION Disrupting the Status Quo: Building Equitable Access to HIV PrEP in the US through Innovative Financing

C. Beyrer, J. Sharfstein, D. Dangerfield, 2022, Journal of Law, Medicine & Ethics.

Assisters Succeed in Insurance Navigation for People Living with HIV and People at Increased Risk of HIV in a Complex Coverage Landscape

K. McManus, J. Keim-Malpass, Amy Killelea, 2020, AIDS research and human retroviruses.

Insurance coverage and financing landscape for HIV treatment and prevention in the USA

R. Walensky, J. Kates, Amy Killelea, 2021, The Lancet.

Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018–2020

K. McManus, R. Khazanchi, Amy Killelea, 2023, Journal of Pharmaceutical Policy and Practice.

Perverse Incentives - HIV Prevention and the 340B Drug Pricing Program.

D. Krakower, J. Marcus, Amy Killelea, 2022, The New England journal of medicine.

Worsening Disparities in State-Level Uptake of Human Immunodeficiency Virus Preexposure Prophylaxis, 2014–2018

K. McManus, E. R. Rogawski McQuade, Amy Killelea, 2021, Open forum infectious diseases.

Economic benefits of the United States’ AIDS drug assistance Program: A systematic review of cost analyses to guide research and policy priorities

K. McManus, J. Keim-Malpass, Amy Killelea, 2022, Preventive medicine reports.